Thus, our study sheds light on the reciprocal interactions between PlGF, hypoxia and the UPR and suggests that the antitumour effects of angiogenesis-modulating therapy could be mediated by modifying the tumour microenvironmental stresses in HCC. This evidence concerns the gene PGF and neoplasm.